Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma Revenue

In the fiscal year ending March 31, 2026, Ajanta Pharma had annual revenue of 56.25B INR with 21.02% growth. Ajanta Pharma had revenue of 14.83B in the quarter ending March 31, 2026, with 26.71% growth.

• Revenue: 56.25B
• Revenue Growth: +21.02%
• P/S Ratio: 6.80
• Revenue / Employee: 5.84M
• Employees: 9,628
• Market Cap: 382.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	56.25B	9.77B	21.02%
Mar 31, 2025	46.48B	4.39B	10.44%
Mar 31, 2024	42.09B	4.66B	12.45%
Mar 31, 2023	37.43B	4.02B	12.02%
Mar 31, 2022	33.41B	4.51B	15.62%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error